Global Emerging Fungal Infection Registry

Lupe

Associates

Chair
Prof. Oliver A. Cornely MD,
FACP, FIDSA, FAAM, FECMM, Cologne

Project Manager
Dr. Danila Seidel PhD,
Cologne

Coordinating Physicians and Quality Control Team Cologne
Dr. Jon Salmanton García PhD
Dr. Philipp Köhler MD
Dr. Jannik Stemler MD
Dr. Sibylle Mellinghoff MD
Stefanie Gräfe MD
Andrea Will

Epidemiology, IT & Statistics
Prof. J. Janne Vehreschild MD, FECMM, Cologne

Microbiology and Sample Storage
Dr. Hilmar Wisplinghoff MD,
Cologne

Molecular Identification
Dr. Volker Rickerts MD,
Berlin

Histopathology
Dr. Birgid Markiefka MD,
Cologne

Thoracic Surgery
Prof. Khosro Hekmat MD,
Cologne

Therapeutic Drug Monitoring
Dr. Carsten Müller MD,
Cologne

Case Definition and Data Entry


You are cordially invited to contribute cases of invasive infections caused by emerging fungi to our registry. The following criteria need to be met for inclusion of a case.

  • Inclusion criteria:
    • Cultural, histopathological or DNA evidence of invasive infection with an emerging fungus*
    • Aspergillosis with at least 3 galactomannan results from day of diagnosis throughout therapy
  • Exclusion criteria:
    • Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jirovecii
    • Endemic fungal infection such as coccidioidomycosis or histoplasmosis
    • Colonisation only or other non-invasive infection

* Examples of emerging fungi:
Acremonium spp., Alternaria spp., Aspergillus terreus, Aureobasidium spp., Bipolaris spp., Cladiophialophora spp., Cladosporium spp., Cryptococcus spp. other than neoformans, Curvularia spp., Exophiala spp., Fusarium spp., Geotrichum spp., Paecilomyces spp., Penicillium spp., Phialophora spp., Scedosporium spp., Trichoderma spp. and Trichosporon spp.


If you would like to collaborate by entering a case,

  1. Please email us your affiliation and we will setup an acocunt for you to access the FungiScope online questionnaire.
  2. Go to FungiScope data entry to access the web based case report form.